| 0 |
Thyroid Hormone Receptor beta Agonist [EPC] |
2 |
0.0009 |
| 1 |
Gadolinium-based Contrast Agent [EPC] |
2 |
0.0004 |
| 2 |
Macrolide Antimicrobial [EPC] |
6 |
0.0001 |
| 3 |
Barbiturate [EPC] |
1 |
0.0001 |
| 4 |
Fluoroquinolone Antibacterial [EPC] |
11 |
0.0001 |
| 5 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
4 |
0.0001 |
| 6 |
Estrogen Receptor Antagonist [EPC] |
3 |
0.0001 |
| 7 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
3 |
0.0001 |
| 8 |
Anticholinergic [EPC] |
1 |
0.0001 |
| 9 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
1 |
0.0001 |
| 10 |
Rifamycin Antibacterial [EPC] |
2 |
0.0001 |
| 11 |
Nucleoside Analog Antiviral [EPC] |
4 |
0.0000 |
| 12 |
Antimycobacterial [EPC] |
1 |
0.0000 |
| 13 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0000 |
| 14 |
PCSK9 Inhibitor [EPC] |
1 |
0.0000 |
| 15 |
Integrin Receptor Antagonist [EPC] |
3 |
0.0000 |
| 16 |
Angiotensin 2 Receptor Blocker [EPC] |
9 |
0.0000 |
| 17 |
Cholinergic Muscarinic Antagonist [EPC] |
1 |
0.0000 |
| 18 |
Pyrimidine Synthesis Inhibitor [EPC] |
1 |
0.0000 |
| 19 |
Erythropoiesis-stimulating Agent [EPC] |
1 |
0.0000 |
| 20 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0000 |
| 21 |
Methylxanthine [EPC] |
1 |
0.0000 |
| 22 |
Potassium Channel Blocker [EPC] |
1 |
0.0000 |
| 23 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 24 |
HER2/neu Receptor Antagonist [EPC] |
1 |
0.0000 |
| 25 |
Central Nervous System Stimulant [EPC] |
1 |
0.0000 |
| 26 |
Partial Opioid Agonist [EPC] |
1 |
0.0000 |
| 27 |
Thiazide Diuretic [EPC] |
2 |
0.0000 |
| 28 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 29 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 30 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 31 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 32 |
Opioid Agonist [EPC] |
2 |
0.0000 |
| 33 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Factor Xa Inhibitor [EPC] |
2 |
0.0000 |
| 35 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 36 |
Loop Diuretic [EPC] |
3 |
0.0000 |
| 37 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 38 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 39 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 40 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 41 |
Platelet Aggregation Inhibitor [EPC] |
3 |
0.0000 |
| 42 |
Endothelin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 43 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
6 |
0.0000 |
| 44 |
Insulin Analog [EPC] |
2 |
0.0000 |
| 45 |
Platinum-based Drug [EPC] |
1 |
0.0000 |
| 46 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 47 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 48 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 49 |
Corticosteroid [EPC] |
4 |
0.0000 |
| 50 |
Vitamin C [EPC] |
1 |
0.0000 |
| 51 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 52 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 53 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 54 |
Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 55 |
Benzodiazepine [EPC] |
1 |
0.0000 |
| 56 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |